A vaccine central in A(H5) influenza antigenic space confers broad immunity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41094140.
- Also identified by DOI 10.1038/s41586-025-09626-3 and PMC identifier 12657240.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Highly pathogenic avian influenza A(H5) viruses globally impact wild and domestic birds, and have caused severe infections in mammals, including humans, underscoring their pandemic potential<sup>1-5</sup>. The antigenic evolution of the A(H5) haemagglutinin (HA) poses challenges for pandemic preparedness and vaccine design<sup>6</sup>. Here the global antigenic evolution of the A(H5) HA was captured in a high-resolution antigenic map. The map was used to design immunogenic and antigenically central vaccine HA antigens, eliciting antibody responses that broadly cover the A(H5) antigenic space. In ferrets, a central antigen protected as well as homologous vaccines against heterologous infection with two antigenically distinct viruses. This work showcases the rational design of subtype-wide influenza A(H5) pre-pandemic vaccines and demonstrates the value of antigenic maps for the evaluation of vaccine-induced immune responses through antibody profiles.
Medical subject headings
- Influenza Vaccines
- Hemagglutinin Glycoproteins, Influenza Virus
- Antigens, Viral
- Influenza A Virus, H5N1 Subtype
- Cross Protection